Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

1.225 -0.025 (-2.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Heartbeam Inc. (NASDAQ: BEAT) Near the Top of Equities by Percentage Gain on 3/20
Via Investor Brand Network
Topics Credit Cards
HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults
Via Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q4, FY 2022 Financial Report, Corporate Updates
Via Investor Brand Network
Topics Earnings Intellectual Property
HeartBeam Reports Fourth Quarter and Full Year 2022 Financial Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Acquires LIVEMOR Assets
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Announces Acquisition of LIVMOR Assets
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) On Track to Advance Innovative Products
Via Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Makes Changes in Senior Leadership Roles
Via Investor Brand Network
HeartBeam Announces Senior Leadership Change
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) CEO Spotlighted in Interview on Making a Positive Social Impact
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Q4 and FY 2022 Results Call
Via Investor Brand Network
HeartBeam to Host Fourth Quarter and Full Year 2022 Results Conference Call on Thursday March 16, 2023 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Recent “Authority” Magazine Interview
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Supports American Heart Month with Commitment to Provide Solutions
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Distinctive Solutions Positioned to Transform the Way Patients, Doctors Detect Heart Attacks
Via Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President
Via Investor Brand Network
HeartBeam Appoints Robert Eno as President
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space
Via Investor Brand Network
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Growing Patent Portfolio Poised to Have Disruptive Effect on Multibillion Markets
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Traders News Source Interview
Via Investor Brand Network
CEO & Founder of Heartbeam Inc. Discusses the Potential for the AIMI(TM) and AIMIGo(TM) Technology in an Audio Interview with TradersNewsSource.com
Via ACCESSWIRE
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Receives Key Patent from European Patent Office
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Shareholder Letter, Including Corporate Update
Via Investor Brand Network
HeartBeam Issues Shareholder Letter and Provides Corporate Update
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology
Via Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Granted Patent for Proprietary ECG Smartwatch-Based Monitor Designed for Heart Attack Detection
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Renowned Cardiologist to Help Define Best Paths to Advance Products
Via Investor Brand Network
HeartBeam (NASDAQ: BEAT) Stands to Disrupt to Multi-Billion-Dollar Patch Market with its Patent-Protected 12-Lead ECG Patch Product
Monitoring a patient’s heart condition is an extensive undertaking considering the current standard of care practices. Up until a few 
Via Spotlight Growth
HeartBeam (NASDAQ: BEAT): Innovative Technologies Disrupting the Old Standard of Care for Heart Patients and Upgrading ECG for the 21st Century
The heart is one of the most essential organs that propel life by pumping blood throughout the body and supporting 
Via Spotlight Growth
Topics Death
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.